The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

Report examines genomic medicine on the NHS

31 January 2012
Appeared in BioNews 642

Genomic medicine will be at the forefront of the NHS, according to a report released last week by the Human Genomics Strategy Group (HGSG). The report highlights the UK's achievements in genomic technology to date and makes six recommendations to ensure future benefit of genomic innovation within the NHS.

'We particularly support the proposal to link genomic data to patients' anonymised medical records through a secure national centre. This would create an unparalleled resource for research and diagnosis without compromising confidentiality or privacy', said Sir Mark Walport, director of the Wellcome Trust, which spends over £100 million a year on genomic research.

With DNA sequencing becoming cheaper and faster - it is now possible to decode the human genome in a day for $1000 - it will soon be possible to routinely map a person's entire genome. This data, linked to medical records, would create the ideal resource for research into personalised medicine.

'It's almost impossible to go forward with the whole personalised medicine agenda, unless you have this database', said Sir John Bell, chair of the HGSG. 'Such a database benefits everybody'.

The details are yet to be finalised, but according to the Telegraph, Dame Sally Davies, the chief medical officer for England who is also a member of the HGSG, said this database was likely to be built up bit-by-bit.

The report also recommends the development of a strategic document to plan how the NHS will adopt such genomic technologies. Some of these are already being used, for example, in patients with specific types of cancer who are offered genetic tests to see whether they are more likely to respond to one treatment or another.

Currently, the NHS has genetic tests available for over 1,000 diseases, including sickle cell anaemia, cystic fibrosis and some forms of cancer, however some researchers feel the report overstates how much these are actually used.

'This report grossly exaggerates the current utility of testing for risk of common, complex diseases', said Dr Stuart Hogarth of King's College London. 'For the most part, at the moment we can do no more than tell people that they are at slightly higher than average risk or slightly lower than average risk'.

Other recommendations include continued development of genomics education and training and raising public awareness of genomic technology and its benefits.

Building on our inheritance
Department of Health report |  25 January 2012
DNA cancer screening plans unveiled
Press Association |  26 January 2012
Genomic innovation will better target treatment in the NHS
Department of Health |  25 January 2012
National DNA database needed for personalised medicine drive
Telegraph |  25 January 2012
NHS to usher in genetic medicine
Independent |  25 January 2012
NHS urged to adopt DNA testing
Financial Times |  25 January 2012
Report highlights benefits of genomic innovation
Department of Health |  25 January 2012
10 July 2017 - by Jennifer Willows 
The Chief Medical Officer of England's annual report has recommended that personalised medicine approaches be adopted widely within the NHS.
13 August 2012 - by Matthew Young 
The anti-doping laboratories built for the London 2012 Olympic and Paralympic Games will be developed into the world's first Phenome Research Centre; the term 'phenome' referring to the overall expression of a person's characteristics and traits as determined by the interaction of genetics and environment...
26 March 2012 - by Dr Rebecca Hill 
Many bioscience graduates lack the practical skills that make them attractive to employers, according to a 2010 survey. In order to fill this skills gap, the Society of Biology launched a degree accreditation programme this week...
12 March 2012 - by Maren Urner 
A single tumour can have many different genetic mutations at various locations, cancer researchers have found. In a study, two thirds of the specific genetic faults identified in tumours were not repeated in the same tumour...
12 March 2012 - by Dr Rebecca Hill 
Genome sequencing for all, the abuse of stored genetic data and red tape halting research are just some of the issues the NHS will have to deal with this year, according to Sir John Burn, professor of clinical genetics at the University of Newcastle, chair of the British Society for Human Genetics (BSHG)...
5 March 2012 - by Ruth Saunders 
A free information resource detailing numerous disease-specific genetic tests that are now available was launched last week by the US National Institutes of Health (NIH)...
20 February 2012 - by Ayesha Jadoon 
With clear and concise information, the 'Genes and Life' DVD serves its purpose as an introduction to the field of genetics. However, it quickly became quite repetitive and lacked the entertainment value that would have taken it beyond merely an educational DVD...
6 February 2012 - by Dr Linda Wijlaars 
The best treatment for tuberculosis (TB) could depend on which version of a particular gene the patient has. Researchers from the UK, US and Vietnam combined studies in zebrafish with clinical work to identify a gene that controls the inflammatory response in TB. It is one of the first applications of personalised medicine outside of cancer medicine...
6 February 2012 - by Dr Stuart Hogarth and Professor Paul Martin 
'Building on our inheritance: Genomic technology in healthcare' is the latest in a long line of reports that have sought to assess the potential of genomic medicine and to outline how policy can best support its development....
9 January 2012 - by Rachel Lloyd 
Personalised healthcare could be one step closer this year, as doctors from the prestigious US Mayo Clinic embark on a project to sequence the full genetic code of thousands of people...
31 October 2011 - by Dr Rebecca Robey 
The NHS must take steps to prepare for a revolution in genetics-based medicine, according to a new report by the independent think tank, the Foundation for Genomics and Public Health (the PHG Foundation). The Foundation says that rapid advances in technology will soon make it possible for individuals to have their entire genome analysed affordably, and this will have a major impact on many aspects of healthcare...
1 August 2011 - by Connie St Louis 
The intersection of racial categories and emerging genetic technology is bound to be vexed given - for example - the long history of eugenics and segregation in the United States. Although the topic has received little attention among the UK general public, pharmaceutical companies on both sides of the Atlantic are investing huge amounts of research and development into individually tailored drugs - pharmacogenetics....
28 March 2011 - by Seil Collins 
A report published by the PHG Foundation argues there needs to be fairer access to genetics in mainstream medicine. It concludes that the UK's current approach to diffusing specialist genomic knowledge and applications into mainstream medical practice is not effective....
21 February 2011 - by Dr Lux Fatimathas 
An article published by a group of international scientists has said an over emphasis on the Human Genome Project (HGP) may risk a 'backlash' in the field of genetics and has called for an evaluation of where the 'real benefits' from genomic medicine will come from....
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.